Articles by Adam Gristwood
The hunt for neutralising antibodies against SARS-CoV-2
Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could potentially stop the infection before it enters the cell.
Jacques Dubochet awarded Nobel Prize for chemistry
EMBL alumnus recognised for cryo-electron microscopy work
EMBL annual reception: bridging nations
EMBL’s annual reception took place on 18 September, with more than 150 attendees
Welcome: James Sharpe
Meet the head of EMBL's new Barcelona site, James Sharpe
Sartorius joins EMBL’s Corporate Partnership Programme
Sartorius and EMBL join forces to support advanced training and science education
Degrees of excellence
Helke Hillebrand on leaving EMBL after 9 years as Academic Coordinator and Dean of Graduate Studies
